Literature DB >> 33689571

Measles seroprevalence among healthcare workers in South Korea during the post-elimination period.

Seung Beom Han1,2, Sun Hee Park1,3, Yunmi Yi1,3, Seul Ki Ji1, So Hee Jang1, Min Hee Park1, Ji Eun Lee1, Hye Sook Jeong1, Soyoung Shin1,4.   

Abstract

During the measles epidemic in 2019, in-hospital transmission of measles contributed to more than two-thirds of measles cases in South Korea, where measles is declared eliminated. This study aimed to examine measles seropositivity among healthcare workers (HCWs) in South Korea to help develop an effective measles prevention strategy for hospital settings. Measles IgG titer was tested in 1,579 HCWs working in a university-affiliated hospital and the measles-containing vaccine (MCV) immunization records of 870 HCWs were identified. The overall seropositivity was 92.0%, but the seropositivity and antibody titers were significantly low among HCWs aged 20-25 years (78.6%) and among one-dose vaccine recipients (86.7%). Among two-dose recipients, seropositivity was lower among young HCWs who received two doses during their childhood than among those who received the catch-up vaccination as part of job requirements (70.3% vs. 98.0%). Among 87 seronegative HCWs who received two-dose MMR vaccination, the seroconversion rate was 98.9%. A considerable proportion of young HCWs were potentially susceptible to measles despite receiving the two-dose vaccination during childhood because of the waning immunity against measles in a country with measles-eliminated status. Serological screening for measles of newly employed HCWs and MCV immunization of seronegative HCWs appears to be an effective prevention strategy.

Entities:  

Keywords:  Measles; South Korea; healthcare worker; seroprevalence; vaccination

Mesh:

Substances:

Year:  2021        PMID: 33689571      PMCID: PMC8475616          DOI: 10.1080/21645515.2021.1888623

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  23 in total

1.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

2.  Comparison of chemiluminescent immunoassay and ELISA for measles IgG and IgM.

Authors:  Fernando de Ory; Teodora Minguito; Pilar Balfagón; Juan C Sanz
Journal:  APMIS       Date:  2015-07-03       Impact factor: 3.205

3.  Workplace vaccination against measles in a teaching hospital of Rome.

Authors:  L Coppeta; A Pietroiusti; L Morucci; A Neri; M Ferraro; A Magrini
Journal:  J Hosp Infect       Date:  2018-12-06       Impact factor: 3.926

4.  Measles in healthcare workers during the ongoing epidemic in Greece, 2017-2018.

Authors:  H C Maltezou; X Dedoukou; A Vernardaki; P Katerelos; E Kostea; S Tsiodras; A Mentis; G Saroglou; M Theodoridou; T Georgakopoulou
Journal:  J Hosp Infect       Date:  2018-06-11       Impact factor: 3.926

Review 5.  The basic reproduction number (R0) of measles: a systematic review.

Authors:  Fiona M Guerra; Shelly Bolotin; Gillian Lim; Jane Heffernan; Shelley L Deeks; Ye Li; Natasha S Crowcroft
Journal:  Lancet Infect Dis       Date:  2017-07-27       Impact factor: 25.071

6.  Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects.

Authors:  Denise Naniche; Michel Garenne; Chris Rae; Marianne Manchester; Richard Buchta; Stephanie K Brodine; Michael B A Oldstone
Journal:  J Infect Dis       Date:  2004-09-08       Impact factor: 5.226

7.  Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.

Authors:  Irja Davidkin; Sari Jokinen; Mia Broman; Pauli Leinikki; Heikki Peltola
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

8.  Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.

Authors:  S Ratnam; V Gadag; R West; J Burris; E Oates; F Stead; N Bouilianne
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

9.  Comparison of the Seroprevalence of Measles Antibodies among Healthcare Workers in Two Korean Hospitals in 2019.

Authors:  Yee Gyung Kwak; Je Eun Song; Gang Bok Oh; In Hye Jeong; Chong Rae Cho; Namhee Kim; Hyeon Mi Yoo; Gyeong Min Yoo; Myung Jin Lee; Baek Nam Kim
Journal:  Infect Chemother       Date:  2020-01-21

Review 10.  Review of Measles in Korea: Quarantine and Elimination.

Authors:  Jin Han Kang
Journal:  Infect Chemother       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.